You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 129 No. 2, February 2003 TABLE OF CONTENTS
  Archives
  •  Online Features
  Clinical Challenges in Otolaryngology
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (21)
 •Contact me when this article is cited
 Related Content
 •Related articles
 •Similar articles in this journal
 Topic Collections
 •Dentistry/ Oral Medicine
 •Radiation Therapy
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Prophylactic Treatment Reduces the Severity of Xerostomia Following Radiation Therapy for Oral Cavity Cancer

Arch Otolaryngol Head Neck Surg. 2003;129:247-250.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Hypothesis: The underlying mechanism of irradiation-induced injury to the salivary glands was an enigma for French radiobiologist Jean Bergonie,1 who first described the phenomenon in 1911. Bergonie was also the scientist who characterized as "radiosensitive" tissues that, like hematological stem cells, are composed of primitive, undifferentiated cells with a high mitotic rate; and yet he was aware that salivary cells, which are highly differentiated (especially serous acinar cells), and have a low mitotic rate, are particularly radiosensitive. The enigma has not been solved and xerostomia still causes much discomfort. Annually, irradiation-induced xerostomia affects between 30 000 and 50 000 individuals treated for head and neck cancer in the United States alone.


 
Figure appears in full text version.
Rafael M. Nagler, DMD, PhD


Since irradiation-induced xerostomia was first described, much research has been devoted to understanding the mechanism of its development. This is due, in part, to its appeal as an enigma; additionally, there is no adequate therapy for . . . [Full Text of this Article]

PRO

CON

BOTTOM LINE



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLES

Xerostomia Prevention After Head and Neck Cancer Treatment
Hadi Seikaly
Arch Otolaryngol Head Neck Surg. 2003;129(2):250-251.
EXTRACT | FULL TEXT  

Clinical Commentary on Prophylactic Treatment of Radiation-Induced Xerostomia
Mark S. Chambers
Arch Otolaryngol Head Neck Surg. 2003;129(2):251-252.
EXTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Radioprotective Effect of Heat Shock Protein 25 on Submandibular Glands of Rats
Lee et al.
Am. J. Pathol. 2006;169:1601-1611.
ABSTRACT | FULL TEXT  

Kinetics of Tempol for Prevention of Xerostomia Following Head and Neck Irradiation in a Mouse Model
Cotrim et al.
Clin. Cancer Res. 2005;11:7564-7568.
ABSTRACT | FULL TEXT  

The Stable Nitroxide Tempol Facilitates Salivary Gland Protection during Head and Neck Irradiation in a Mouse Model
Vitolo et al.
Clin. Cancer Res. 2004;10:1807-1812.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2003 American Medical Association. All Rights Reserved.